Note: Ingredients listed on restricted chemical lists
EC/CAS
58-55-9
Name of the chemical
Theophyllin; 1,3-Dimethyl-3,7-dihydro-1H-purin-2,6-dion (2022/692)
Concentration
N/A
EC/CAS
77-93-0
Name of the chemical
citric acid, triethyl ester
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2021-11-19
Product name
THEOVENT TABLETS 300
Product Synonyms
THEOVENT TABLETS 300 MG * THEOVENT 300 PROLONGATUM TABLETKI 300 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
Tianjin SmithKline (GSK) Laboratory Co. Ltd.
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Emergency overview Toxic if swallowed. Prolonged exposure may cause chronic effects. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Hazard statements
categories H301 Toxic if swallowed.
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 3 See section 11 for additional information on health hazards.
Environmental hazards
Not classified. The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Signal word
Danger
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTRE/doctor/. P330 Rinse mouth. P321 Specific treatment (see this label).
Storage
P405 Store locked up.
Disposal
None.
Other physicochemical hazards
The product is stable and non-reactive under normal conditions of use, storage and transport.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
32.59 % of the mixture consists of component(s) of unknown acute oral toxicity. 37.59 % of the mixture consists of component(s) of unknown acute dermal toxicity. 32.03 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 38.68 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 38.68 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
